These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31408769)

  • 21. The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.
    Kigozi J; Jowett S; Lewis M; Barton P; Coast J
    Value Health; 2017 Mar; 20(3):496-506. PubMed ID: 28292496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerations Around the Inclusion of Children and Young People's Time in Economic Evaluation: Findings from an International Delphi Study.
    Morgan C; Donaldson C; Lancsar E; Petrou S; Andronis L
    Pharmacoeconomics; 2024 Nov; 42(11):1267-1277. PubMed ID: 39153138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.
    Bouwmans C; Krol M; Severens H; Koopmanschap M; Brouwer W; Hakkaart-van Roijen L
    Value Health; 2015 Sep; 18(6):753-8. PubMed ID: 26409601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Welfare, QALYs, and costs - a comment.
    Liljas B
    Health Econ; 2011 Jan; 20(1):68-72. PubMed ID: 21157833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to calculate indirect costs in economic evaluations.
    Liljas B
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):1-7. PubMed ID: 10175982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valuing care recipient and family caregiver time: a comparison of methods.
    Guerriere DN; Tranmer JE; Ungar WJ; Manoharan V; Coyte PC
    Int J Technol Assess Health Care; 2008; 24(1):52-9. PubMed ID: 18218169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using economic evaluations to reduce the burden of asthma and chronic obstructive pulmonary disease.
    Sculpher M
    Pharmacoeconomics; 2001; 19 Suppl 2():21-5. PubMed ID: 11700785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation and mental health: sparse past. fertile future?
    Knapp M
    J Ment Health Policy Econ; 1999 Dec; 2(4):163-167. PubMed ID: 11967427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valuing patient and caregiver time: a review of the literature.
    Tranmer JE; Guerriere DN; Ungar WJ; Coyte PC
    Pharmacoeconomics; 2005; 23(5):449-59. PubMed ID: 15896097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises.
    Krol M; Sendi P; Brouwer W
    Value Health; 2009; 12(1):172-80. PubMed ID: 18647262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What are economic costs and when should they be used in health economic studies?
    Turner HC; Sandmann FG; Downey LE; Orangi S; Teerawattananon Y; Vassall A; Jit M
    Cost Eff Resour Alloc; 2023 May; 21(1):31. PubMed ID: 37189118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives.
    Farrar MA; Carey KA; Paguinto SG; Chambers G; Kasparian NA
    BMJ Open; 2018 May; 8(5):e020907. PubMed ID: 29794098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington Panel.
    Brouwer WB; Koopmanschap MA; Rutten FF
    Int J Technol Assess Health Care; 1998; 14(3):505-13. PubMed ID: 9780537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the opportunity costs of bed-days.
    Sandmann FG; Robotham JV; Deeny SR; Edmunds WJ; Jit M
    Health Econ; 2018 Mar; 27(3):592-605. PubMed ID: 29105894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fundamentals of clinical economics in health interventions.
    Awasthi S
    Indian J Pediatr; 2000 May; 67(5):352-7. PubMed ID: 10885208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should Cost-Effectiveness Analysis Include the Cost of Consumption Activities? AN Empirical Investigation.
    Adarkwah CC; Sadoghi A; Gandjour A
    Health Econ; 2016 Feb; 25(2):249-56. PubMed ID: 25684073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monetary Valuation of Children's Cognitive Outcomes in Economic Evaluations from a Societal Perspective: A Review.
    Grosse SD; Zhou Y
    Children (Basel); 2021 Apr; 8(5):. PubMed ID: 33946651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review.
    Campbell JA; Venn A; Neil A; Hensher M; Sharman M; Palmer AJ
    Obes Rev; 2016 Sep; 17(9):850-94. PubMed ID: 27383557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
    Donaldson C; Birch S; Gafni A
    Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.